Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs01:21

Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs

2.0K
The fundamental mathematical principles, such as calculus and graphs, play crucial roles in analyzing drug movement and determining pharmacokinetic parameters. Differential calculus examines rates of change and helps to determine the dissolution rate of drugs in biofluids, as well as how drug concentrations change over time. For instance, it can help calculate the rate of elimination of a drug from the body based on its concentration-time profile.
On the other hand, integral calculus focuses on...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary mRNA-LNP vaccines for rapid and durable protection against bacterial infection.

Nature communications·2026
Same author

HuBMAP Data Portal: A Resource for Multimodal Spatial and Single-Cell Data of Healthy Human Tissues.

ArXiv·2026
Same author

Multimodal Patient-Specific Identification of Atrial Flutter Circuits From ECG Time Series Using Explainable Machine Learning.

IEEE journal of translational engineering in health and medicine·2026
Same author

Antithetic Sampling Enhanced Probabilistic Diffusion for Denoising Cardiac Time Series.

IEEE journal of biomedical and health informatics·2026
Same author

Integrating spatial and single-cell transcriptomics via machine learning to characterize efferocytosis in hepatocellular carcinoma prognosis and immunotherapy.

Translational oncology·2026
Same author

Fast Zinc-ion Shuttle Channel with Built-in Ion-anchors Enables Reversible and Sustainable Zinc Metal Anodes.

Small (Weinheim an der Bergstrasse, Germany)·2026

Related Experiment Video

Updated: Sep 11, 2025

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models
06:22

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

3.9K

Mathematical models and computational approaches in CAR-T therapeutics.

Guido Putignano1,2, Samuel Ruipérez-Campillo3,4, Zhou Yuan5

  • 1bioERGOtech, Taranto, Italy.

Frontiers in Immunology
|August 18, 2025
PubMed
Summary

Mathematical models can improve CAR-T cell therapy by enhancing design and predicting outcomes. This approach addresses challenges like antigen escape and cytokine release syndrome for better cancer treatment.

Keywords:
CAR-T cellsT cell engineeringbiological system modelingcomputational immunotherapymathematical modelingsynthetic biologytherapeutic optimization

More Related Videos

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
09:12

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

1.0K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

791

Related Experiment Videos

Last Updated: Sep 11, 2025

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models
06:22

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

3.9K
Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
09:12

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

1.0K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

791

Area of Science:

  • Synthetic biology
  • Immunotherapy
  • Computational biology

Background:

  • Chimeric antigen receptor (CAR)-T cell therapy is a promising cancer treatment.
  • Current models lack spatio-temporal resolution, limiting CAR-T therapy for solid tumors.
  • Challenges include safety, cost-effectiveness, and predicting therapeutic outcomes.

Purpose of the Study:

  • To explore mathematical models and computational techniques for CAR-T therapy.
  • To enhance CAR-T therapy design and predict treatment outcomes.
  • To address critical factors like antigen receptor functionality and adverse effects.

Main Methods:

  • Examining CAR-T cell dynamics and antigen binding.
  • Investigating strategies to overcome antigen escape and cytokine release syndrome.
  • Utilizing mathematical modeling for predicting therapeutic efficacy and relapse.

Main Results:

  • Mathematical models offer enhanced spatio-temporal resolution for CAR-T therapy.
  • Computational techniques can predict treatment efficacy and potential adverse effects.
  • Models aid in developing strategies to manage challenges like antigen escape and relapse.

Conclusions:

  • A comprehensive framework using mathematical models can advance CAR-T cell therapy.
  • Bridging existing methods with modeling enhances CAR-T engineering potential.
  • This approach aims to improve clinical applications of CAR-T therapy.